Management of teratoma

Area of Science:

• Oncology
• Pediatric Oncology
• Surgical Oncology

Background:

• Teratomas exhibit distinct behavior based on patient age, being benign in prepubertal children and malignant in adolescents and adults.
• Understanding the age-dependent behavior of teratomas is crucial for appropriate clinical management and treatment strategies.

Purpose of the Study:

• To delineate the differential diagnosis and management strategies for teratomas across different age groups.
• To highlight the role of surgery in managing teratomas, particularly in adult patients with metastatic disease.

Main Methods:

• Review of clinical presentation and treatment outcomes for teratomas in prepubertal children versus adolescents and adults.
• Analysis of the efficacy of surveillance, orchiectomy, chemotherapy, and surgical resection in managing teratomas and their metastases.

Main Results:

• In prepubertal children, teratomas are typically benign, often managed with orchiectomy or enucleation if solely teratomatous.
• In adults, teratomas behave as malignant neoplasms; surgical management is preferred for residual or metastatic teratomatous masses, as they are chemotherapy-resistant.
• Chemotherapy may be used for larger metastases to address other germ cell elements, with subsequent surgical excision of persistent teratomatous components.

Conclusions:

• The management of teratomas requires an age-specific approach, distinguishing between benign pediatric and malignant adult presentations.
• Surgery plays a pivotal role in the definitive treatment of adult teratomas and residual teratomatous masses post-chemotherapy.
• Surveillance may be an option for select adult patients post-orchiectomy without evidence of metastases.